Align Technology, Inc. (ALGN) vs Axsome Therapeutics, Inc. (AXSM)

A side-by-side comparison of Align Technology, Inc. and Axsome Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALGN vs AXSM

growth of $100 · dividends reinvested · last 10y
ALGN +52.2% (+4.3%/yr)AXSM +2054.3% (+35.9%/yr)AXSM compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020182020202220242026$152$2,154
ALGN AXSM

ALGN vs AXSM: by the numbers

  • •ALGN is the larger company ($10.13B vs $8.97B market cap).
  • •ALGN is profitable (9.99% net margin) while AXSM runs a net loss (-24.68%).

Metrics side by side

Valuation

MetricALGNAXSM
P/E ratio24.56N/A
Forward P/E12.55N/A
P/S ratio2.4511.55
P/B ratio2.39107.70
EV / EBITDA11.35N/A

Profitability

MetricALGNAXSM
Gross margin66.48%93.24%
Operating margin13.33%-24.28%
Net margin9.99%-24.68%
ROE9.77%-230.05%
ROIC8.90%-50.82%

Growth (annualized)

MetricALGNAXSM
Revenue CAGR (5Y)3.57%N/A
EPS CAGR (5Y)-24.16%N/A
Total return CAGR (5Y)-26.34%41.40%

Some values include inputs from SEC filing.

Frequently asked

Is ALGN or AXSM more profitable?
ALGN runs the higher net margin — ALGN at 9.99% versus AXSM at -24.68%.
How have ALGN and AXSM total returns compared?
Over the past 10 years, ALGN delivered 4.63% and AXSM delivered 35.76% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.